ArticlePain and therapy2020

The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine.

Stephen D Silberstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.